Skip to main content

  • Ophthalmic Business Council

    For more than 30 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.

    OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.

    To join or learn more, contact Todd Lyckberg at 415.447.0361 or tlyckberg@aao.org.

    Download brochure: OBC Membership 2024-25


    Save the Date

    Fall 2024 Symposium
    Sept. 12-13, 2024
    San Francisco, Calif.

    Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.

    Spring 2025 Symposium
    April 3, 2025
    Washington, DC

    The Spring Symposium is held every other year in Washington, D.C. It features experts from government agencies presenting updates on FDA, Medicare and reimbursement issues. As the speed of innovation and new knowledge in ophthalmology grows, this event has become increasingly valuable in providing helpful insights for bringing new technologies and procedures to patients. 


    Member Benefits

    2023 - 2024 Ophthalmic Business Council 


    Crown Benefactors ($35,000)

    Alcon Inc.
    Allergan, an AbbVie Company
    Genentech Inc.
    Horizon Therapeutics
    Regeneron Pharmaceuticals Inc.

     
    Benefactors ($25,000)

    Dompé
    The Janssen Pharmaceutical Companies of Johnson & Johnson
    Sight Sciences Inc.


    Patrons ($15,000)

    Amgen Inc.
    Apellis Pharmaceuticals
    Bausch + Lomb
    Biogen
    Boehringer Ingelheim
    Carl Zeiss Meditec Inc.
    Glaukos Corporation
    Johnson & Johnson Vision
    Optos Inc.

     
    Subscribers ($7,500)

    Astellas Inc.
    Bio-Tissue Inc.
    Coherus BioSciences Inc.
    Eyenuk Inc.
    EyePoint Pharmaceuticals
    Leadiant Biosciences Inc.
    Notal Vision
    Ocular Therapeutix
    REGENXBIO Inc.
    Sun Ophthalmics
    Verana Health
    Viridian Therapeutics

    Members ($5,000)

    Santen
    Tarsus Pharmaceuticals Inc.

    Associate Members ($2,500)

    Elios Vision
    Immunovant Inc.
    Versea Ophthalmics
    W. L. Gore & Associates